Skip to content
Disclosery

EXANE DERIVATIVES: BSX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on BSX, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 43,067 BSX shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 43,067 shares
    Change vs previous 13F -2,859 shares

    0.92% of the 13F portfolio, value $1,604,911.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 45,926 shares
    Change vs previous 13F -3,459 shares

    0.57% of the 13F portfolio, value $2,034,077.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 49,385 shares
    Change vs previous 13F -47,037 shares

    0.51% of the 13F portfolio, value $2,097,942.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 96,422 shares
    Change vs previous 13F -3,695 shares

    1.04% of the 13F portfolio, value $4,183,887.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 100,117 shares
    Change vs previous 13F +7,755 shares

    1.01% of the 13F portfolio, value $4,311,117.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 92,362 shares
    Change vs previous 13F -16,414 shares

    1.08% of the 13F portfolio, value $3,569,927.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 108,776 shares
    Change vs previous 13F +11,024 shares

    1.19% of the 13F portfolio, value $3,910,638.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 97,752 shares
    Change vs previous 13F not available

    1.22% of the 13F portfolio, value $3,735,179.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).